Next Article in Journal
Which Out-of-Hospital Cardiac Arrest Patients without ST-Segment Elevation Benefit from Early Coronary Angiography? Results from the Korean Hypothermia Network Prospective Registry
Next Article in Special Issue
Automated Red Cell Exchange in the Management of Sickle Cell Disease
Previous Article in Journal
Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging Disease
Previous Article in Special Issue
Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic

Cardeza Foundation for Hematologic Research, Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
J. Clin. Med. 2021, 10(3), 438; https://doi.org/10.3390/jcm10030438
Submission received: 8 December 2020 / Revised: 11 January 2021 / Accepted: 14 January 2021 / Published: 23 January 2021

Abstract

Sickle cell disease (SCD) is an inherited disorder of hemoglobin structure. The clinical effects of the sickle gene are pleiotropic in nature causing multiple phenotypic expressions associated with the various complications of the disease. The hallmark of the disease is pain that could be acute, chronic, nociceptive, or neuropathic that could occur singly or in various combinations. The acute vaso-occlusive painful crisis (VOC) is the most common cause of admissions to the Emergency Department and/or the hospital. Although progress has been made in understanding the pathophysiology of SCD as well as in developing preventive and curative therapies, effective pain management continues to lag behind and depend mostly on the use of opioids. This review describes the history of opioids from the ancient times of opium to the current use of the many controversial opioids. In addition, the major cause of death of patients with SCD is the complications of the disease itself and not the use of opioids. The use of opioids by patients with SCD has been stable over the years. Judicious use of opioids to treat sickle cell pain according to available guidelines could minimize the unnecessary suffering experienced by patients with SCD.
Keywords: sickle cell disease; opium; opioids; epidemic; mortality; pandemic sickle cell disease; opium; opioids; epidemic; mortality; pandemic

Share and Cite

MDPI and ACS Style

Ballas, S.K. Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic. J. Clin. Med. 2021, 10, 438. https://doi.org/10.3390/jcm10030438

AMA Style

Ballas SK. Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic. Journal of Clinical Medicine. 2021; 10(3):438. https://doi.org/10.3390/jcm10030438

Chicago/Turabian Style

Ballas, Samir K. 2021. "Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic" Journal of Clinical Medicine 10, no. 3: 438. https://doi.org/10.3390/jcm10030438

APA Style

Ballas, S. K. (2021). Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic. Journal of Clinical Medicine, 10(3), 438. https://doi.org/10.3390/jcm10030438

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop